menu
    • menu

    Company profile for Scinai Immunotherapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offe...
    Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Scinai ImmunotherapeuticsIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Jerusalem BioPark Hadassah Ein Kerem campus Jerusalem
    Telephone
    Telephone
    +972 89302529
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.scinai.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/scinai/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/scinai_

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Scinai Expands Fill-And-Finish CDMO With Israel Innovation
    Scinai Expands Fill-And-Finish CDMO With Israel Innovation

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-awarded-israel-innovation-authority-grant-to-expand-fill-and-finish-cdmo-capabilities-302575646.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share
    Scinai Showcases Strong 2025 CDMO Revenue Growth in Six-Month
    Scinai Showcases Strong 2025 CDMO Revenue Growth in Six-Month

    02 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-reports-six-month-2025-financial-results-highlighting-continued-cdmo-revenue-growth-and-strengthened-balance-sheet-302543710.html

    PR NEWSWIRE
    02 Sep 2025
    Share Share
    Scinai's PC111 Proven as Disease-Modifying Therapy for Pemphigus
    Scinai's PC111 Proven as Disease-Modifying Therapy for Pemphigus

    29 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-announces-new-peer-reviewed-publication-supporting-pc111-as-a-disease-modifying-therapy-for-pemphigus-and-sjsten-302516002.html

    PR NEWSWIRE
    29 Jul 2025
    Share Share
    Scinai Immuno’s PC111 Wins Top Italian Dermatology Award
    Scinai Immuno’s PC111 Wins Top Italian Dermatology Award

    26 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-highlights-award-winning-science-behind-pc111-as-key-pincell-researcher-receives-oscar-of-italian-dermatology-302492178.html

    PR NEWSWIRE
    26 Jun 2025
    Share Share
    Scinai Highlights Funding & Growth for BIO Int'l Convention 2025
    Scinai Highlights Funding & Growth for BIO Int'l Convention 2025

    12 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-highlights-new-funding-and-cdmo-growth-ahead-of-bio-international-convention-2025-302480183.html

    PR NEWSWIRE
    12 Jun 2025
    Share Share
    Scinai Gets Italy’s Golden Power OK for Pincell Acquisition
    Scinai Gets Italy’s Golden Power OK for Pincell Acquisition

    05 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/scinai-immunotherapeutics-receives-italian-government-clearance-under-golden-power-regulation-for-potential-acquisition-of-pincell-srl-302474330.html

    PR NEWSWIRE
    05 Jun 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search